Insider trade

Oragenics (OGEN)Director sold ~$198

Fred Telling, Director at Oragenics, sold ~$198 of Oragenics shares.

~$198
Approx. value · 210 sh @ $0.9446: 948
Holds after · shares reported

Traded: Dec 12, 2025
Filed: Jan 22, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 16, 2025Company filing · Form 8-K · Material agreement, Listing noticeReceived a notice from its stock exchange, and signed an important agreement (and 1 more item)“On October 20, 2025, Oragenics, Inc. (the “ Company ”) received a letter from the NYSE American informing the Company it has regained compliance with the stockholder’s equity requirements of the NYSE American continued listing standards.”
Dec 11, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“(e) Compensatory Arrangements of Certain Officers.”
Dec 12, 2025 · this disclosureInsiderDirector sold ~$198 of OGEN shares in the open market

What came next

Jan 22, 2026Company filing · Form 8-K · Material agreementSigned an important agreement

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Oragenics

OQRO holds no insider, Congress, fund or contract record for Oragenics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OGEN page.

Other recent filings by Fred Telling, Director

SEC Form 4 at Oragenics (OGEN)Dec 9, 2024

The full history of Fred Telling, Director is on the profile page.

How this filing works

Other disclosures at Oragenics

Everything OQRO holds on this company is on its OGEN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data